Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
15/10/2026 23:30
BRIEF-FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed Oct 15 (Reuters) - Edwards Lifesciences Corporation EW.N:
FDA: AWARE EDWARDS LIFESCIENCES ISSUED LETTER RECOMMENDING SOME DELIVERY SYSTEMS USED FOR SAPIEN M3 TRANSCATHETER MITRAL VALVE REPLACEMENT BE REMOVED
FDA: AS OF OCT 5, EDWARDS LIFESCIENCES REPORTS ONE DEATH, ONE SERIOUS INJURY ASSOCIATED WITH ISSUE - WEBSITE
Source text: [ID:]
Further company coverage: EW.N
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals